PHARMACIST AS A PRIMARY-CARE PROVIDER IN A TUBERCULOSIS CLINIC

被引：8

作者：

COLEMAN, LT

ADAMS, WC

GONG, WC

机构：

[1] BROTMAN MED CTR,CULVER CITY,CA

[2] UNIV SO CALIF,SCH PHARM,LOS ANGELES,CA 90007

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1983年 / 40卷 / 02期

关键词：

D O I：

10.1093/ajhp/40.2.278

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：278 / 281

页数：4

共 16 条

[1] TREATMENT OF PULMONARY TUBERCULOSIS - CURRENT OPTIONS [J].

ADDINGTON, WW .

ARCHIVES OF INTERNAL MEDICINE, 1979, 139 (12) :1391-1395

[2] ISONIAZID TOXICITY - PROSPECTIVE STUDY IN SECONDARY CHEMOPROPHYLAXIS [J].

BYRD, RB ;

ELLIOTT, RC ;

NELSON, R .

JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1972, 220 (11) :1471-+

[3] PHARMACIST INVOLVEMENT IN A TUBERCULOSIS OUTPATIENT-CLINIC [J].

DAYTON, CS .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1978, 35 (06) :708-710

[4]

DUTT AK, 1980, J RESPIR DIS, V1, P12

[5] ADVERSE REACTIONS TO RIFAMPICIN IN ANTITUBERCULOSIS REGIMENS [J].

GIRLING, DJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1977, 3 (02) :115-132

[6] ISONIAZID - REVIEW WITH EMPHASIS ON ADVERSE EFFECTS [J].

GOLDMAN, AL ;

BRAMAN, SS .

CHEST, 1972, 62 (01) :71-&

[7]

GROSSET J, 1980, CLIN CHEST MED, V1, P231

[8] DRUG REACTIONS .18. CUTANEOUS REACTIONS TO ANTITUBERCULOUS DRUGS [J].

LEVANTINE, A ;

ALMEYDA, J .

BRITISH JOURNAL OF DERMATOLOGY, 1972, 86 (06) :651-+

[9]

MANDELL GL, 1980, PHARMACOL BASIS THER, P1200

[10]

MEYER H, 1980, MEYLERS SIDE EFFECTS, P524

← 1 2 →